Moritz Bleibtreu invests in Bloomwell

With the new capital, the cannabis start-up wants to prepare for its expected legalization as a stimulant in Germany.
Bloomwell Group has raised several million euros in a financing round. The round is led by Artemis Growth Partners, an American investment fund specializing in cannabis companies. In addition to actor Moritz Bleibtreu, existing investor Measure 8 Venture Partners and a German family office are investing in the cannabis company. The exact amount of funding is not known.
Founded in 2020, the startup acts as a holding company for medical cannabis companies. Now Bloomwell wants to prepare for the expected legalization of cannabis as a stimulant in Germany. "Now that we have a fully funded company, the focus is solely on innovation and growth," says Niklas Kouparanis, co-founder and CEO of Bloomwell. The company plans to use the new capital to further expand its market share.
Actor and investor Moritz Bleibtreu wants to advocate for the destigmatization of cannabis in medicine. "The cannabis plant can help many people live a better life. We should therefore stop pigeonholing a plant on the basis of prejudices that have been handed down for decades," says Bleibtreu.

Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies

FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?